10X Genomics Inc (TXG) — Cash Flow Quality Index

Latest as of June 2025: 0.51x

10X Genomics Inc (TXG) has a Cash Flow Quality Index of 0.51x as of June 2025. Operating cash flow of $17.71 Million is below net income of $34.54 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of 10X Genomics Inc to assess how effectively this company generates cash.

Cash Flow Quality Index

0.51x

Operating CF / Net Income

Operating Cash Flow

$17.71 Million

USD

Net Income

$34.54 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for 10X Genomics Inc (None–None)

Year-by-year earnings quality comparison for 10X Genomics Inc. For live market cap and the full company financial profile, see market cap of 10X Genomics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.